Ocular delivery (Focus Group - OcD)

Challenges and opportunities unique to the treatment of vision-threatening diseases (e.g., dry eye disease, cystinosis, posterior capsule opacification, retinal degenerative diseases, glaucoma, optic neuropathy, ocular injuries, etc); design of advanced drug delivery systems, extended release formulations, and drug-device combinations for ophthalmic applications, such as eye drops, contact lenses, punctal plugs, injectables, intravitreal devices, suprachoroidal delivery, ultrasound mediated delivery; overcoming physiological barriers in ocular drug delivery (e.g., corneal epithelial barrier, blood-retinal-barrier, aqueous humor turnover, etc).

Poster #	First Name	Last Name	Abstract Title	Abstract
299	Sandeep	Nema	A novel co-encapsulated mRNA-DNA LNP formulation for targeted delivery of ABCA4 to photoreceptors in Stargardt disease	View
870	Giulia	Accomasso	Solid Lipid Nanoparticles as a novel intravitreal approach in the treatment of Macular Degeneration	View
871	Myasar	Al-kotaji	Ciprofloxacin ophthalmic in-situ gel based on a combination of two poloxamers	View
872	Lucía	Bernat-Just	Ocular drug delivery systems: ex vivo diffusion studies of hydroxytyrosol from an ocular insert.	View
873	Santosh Sahadu	Bhujbal	Formulation and characterization of transfersomes for ocular drug delivery	View
874	Joshua	Boateng	Hyaluronic acid based films as potential ocular drug delivery platforms for treatment of glaucoma	View
875	Sai Hanuman Sagar	Boddu	Design and optimization of acetazolamide nanoparticle-laden contact lens using statistical experimental design for controlled ocular drug delivery	View
876	Marco	Brugnera	Latanoprost-Loaded Liposomes with Sodium Hyaluronate, Betaine and Leucine as Well-tolerated and Effective Topical Antiglaucoma Option	View
877	Asma	Buanz	Fabrication of Drug-eluting contact lenses using vat photo-polymerisation 3D printing	View
878	Angel	Concheiro	Ocular delivery of epalrestat using oleogels, micelles and niosomes	View
879	Carolina	Costa	Triamcinolone acetonide-eluting contact lenses based on cyclodextrins to manage chronic retinal diseases	View
880	Carolina	Costa	Nepafenac-eluting bandage contact lenses for macular edema prophylaxis after cataract surgery	View
881	Elliot	Croft	Ocular Drug Delivery: Dissolving Microneedle Array Patches for Sustained Release in the Treatment of Glaucoma	View
882	Armando	da Silva Cunha Junior	Tacrolimus loaded nanostructured polymeric systems for dry eye treatment.	View
883	Mickael	Dang	Towards A Long-Acting Hydrogel-Nanoparticle Depot for the Treatment of Primary Open-Angle Glaucoma	View
884	Ridhdhi	Dave	Dynamically Cross-linked Degradable Mucoadhesive Microgels	View
885	Kaat	De Clerck	Characterization of enhanced lipid nanoparticle delivery to the retina after photodisruption of the inner limiting membrane	View
886	Valerie	Eta	Optimizing Injectable in situ Forming Implants for Sustained Release of Ophthalmic Therapeutics	View
887	Gabriela	Galvão	Development of an Ex Vivo Model for Investigating Iontophoresis-Assisted Ophthalmic Drug Penetration	View
888	Meredith	Garrett	A Biorelevant in vitro Release Testing Method for Long-Acting Intraocular Injections	View
889	Katie	Glover	Establishing correlations between lab-scale models in the development of ocular microneedles	View
890	Tais	Gratieri	Resistance of topical Ophthalmic Drug Products in the novel in vitro OphthalMimic device	View
891	Melitini	Koutsoviti	Influence of polysorbate 80 on adsorption of lysozyme onto drug particles in the context of protein corona in ocular fluids	View
892	Lina	Liu	Soft contact lens materials containing poly(HEMA /TRIS) nanoparticles for drug delivery	View
893	Josip	Ljubica	Loteprednol etabonate and ibuprofen-loaded nanoemulsions: valuable therapeutic option for patients with mild-to-moderate dry eye disease	View
895	Amber	Monteiro	Development of Drug Delivery Vehicle for Gene Silencing in the Posterior Segment of the Eye	View
896	Carola	Guerra	NANOFIBER-COATED INTRAVITREAL DEVICE: A NEW STRATEGY FOR AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT	View
897	Ye Jin	Park	Development and evaluation of hot-melt–extruded diquafosol tetrasodium formulations for ophthalmic inserts: A design of experiments approach	View
898	Jahnavi	Pejavar	A peptide-sunitinib conjugate provides sustained retinal neuroprotection with topical administration	View
899	Rosario	Pignatello	Encapsulation of antibacterial drugs in fusogenic liposomes for ophthalmic application.	View
900	Sergei	Raik	Polysaccharide based polyplexes for ocular gene delivery: extracellular barriers.	View
901	Pouria	Ramezani	Nano and conjugated photosensitizers for enhanced laser treatment of eye floaters by laser-induced nanobubbles	View
903	Diana	Silva	Tailored hydrogel for contact lenses with low friction and anti-inflammatory releasing ability	View
904	Katelyn	Swindle-Reilly	Redox-Responsive Nanoparticle System for Tyrosine Kinase Inhibitor Delivery to Treat Retinal Conditions	View
905	Phuong Linh	Ta	Preliminary ex vivo diffusion studies of ocular inserts containing α-lipoic acid in a β-cyclodextrin complex	View
906	Nadia	Toffoletto	Antioxidant contact lenses for the prevention and treatment of diabetic ocular diseases	View
907	Vasiliki	Tsikourkitoudi	Nanoparticle-based NAD-boosting drug delivery system for glaucoma treatment	View
908	Eetu	Valkama	Pegylated DOPC liposomes enable multi day drug release of inhibitory cGMP analogue after intravitreal injection.	View
909	Lalitkumar K.	Vora	Polymer-free HPβCD-electrospun implants loaded with fenofibrate could depress choroidal angiogenesis upon episcleral application	View
910	Yoshiko	Yamazaki	Development of composite device of amorphous carbon-polymer material using porous material and its application evaluation	View
911	Elide	Zingale	Self-nanoemulsifying drug delivery systems (SNEDDS) as a platform for ocular delivery of curcumin in retinal diseases	View
1176	María	Formica	Novel acetazolamide-loaded nanostructured lipid carriers for ocular applications	View